A point mutation in PTPRC is associated with the development of multiple sclerosis

Area of Science:

• Neuroimmunology
• Genetics of Neurological Disorders

Background:

• Multiple sclerosis (MS) is a primary demyelinating condition of the central nervous system.
• The pathogenesis of MS is not fully understood but involves immune system dysregulation.
• Genetic factors are implicated in MS, yet specific genes remain largely unidentified.

Purpose of the Study:

• To investigate the potential role of a specific point mutation in the PTPRC gene, encoding protein-tyrosine phosphatase, receptor-type C (CD45), in the development of MS.
• To examine the impact of this PTPRC mutation on CD45 isoform expression in immune cells.

Main Methods:

• Case-control studies involving multiple independent cohorts.
• Analysis of MS nuclear families to assess genetic linkage and association.
• Evaluation of CD45 protein expression phenotypes in affected individuals.

Main Results:

• A significant association between the PTPRC mutation and MS was observed in three out of four case-control studies.
• The PTPRC mutation was found to be genetically linked and associated with MS in three affected nuclear families.
• A similar CD45 variant phenotype was identified in MS patients from an additional family, suggesting a potential common genetic or phenotypic link.

Conclusions:

• The findings suggest a notable association between the investigated PTPRC gene mutation and the development of MS in certain familial cases.
• This mutation may influence mRNA splicing, leading to altered CD45 isoform expression and potentially contributing to MS pathogenesis.
• Further research is warranted to elucidate the precise mechanisms by which PTPRC mutations contribute to MS susceptibility.